Press Releases
WASHINGTON--(BUSINESS WIRE)-- FiscalNote Holdings, Inc. (NYSE: NOTE) ("FiscalNote"), a leading AI-driven enterprise SaaS technology provider of global policy and market intelligence, today announced that members of the senior management team will be participating in the following upcoming conferences:
- Oppenheimer & Co. 9th Annual Emerging Growth Conference - Thursday, May 9, 2024. FiscalNote will participate virtually and host investor meetings.
EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter 2024 financial and operating results.
Tower segment’s financial results will be presented as discontinued operations in the Company’s Consolidated Financial Statements. Under the new organizational and reporting structure, the Company has one reportable segment in continuing operations.
First... (continue reading...)
ALMATY, Kazakhstan, May 3, 2024 /PRNewswire/ -- Narxoz University, a leading private university in Kazakhstan and member of Bulat Utemuratov's Group, is pleased to announce that it has entered into a ground-breaking partnership with Queen's University Belfast, a Russell Group university, to еstablish a branch at Narxoz's new campus. The branch will provide students in Kazakhstan with access to Queen's University's academic programs.
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, has been named to the inaugural 2024 TIME100 Health, an annual list recognizing the impact, innovation, and achievement of the world’s most influential individuals in health... (continue reading...)
- Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024 and of 6-month open-label extension phase in Q1 2025
- Phase 2a clinical trial of GH001 in postpartum depression on track for expected completion in Q3 2024
- Cash, cash equivalents, other financial assets and marketable securities of $214.0 million expected to provide cash runway into 2026
DUBLIN, Ireland, May 03, 2024 (GLOBE... (continue reading...)
More Press Releases
View Older Stories-
Uniti to Merge with Windstream Creating Premier Insurgent Fiber Provider
-
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
-
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BNCCORP, INC. REPORTS FIRST QUARTER NET INCOME OF $1.7 MILLION, OR $0.49 PER DILUTED SHARE
-
T&Pm Launches First U.S. Marketing Campaign for British Womenswear Label ME+EM
-
Clayton® Unveils First Encore Home at 2024 Berkshire Hathaway Annual Shareholders Meeting
-
Mubadala Capital Portfolio Company TruFood Manufacturing to Combine with Bar Bakers
-
Knock Dinner Out of the Park with Beef
-
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
-
Fulgent Reports First Quarter 2024 Financial Results
-
Ratliff & Taylor Expands Executive Search Practice to Support Regional Demand and Growth
-
Eagle Mountain-Saginaw Independent School District Selects Varsity Tutors for Schools to Provide Students with Additional Learning Resources
-
Dr. Jonathan Lewin Performs the First Surgery in the State of New Jersey with PathKeeper Surgical Spinal Navigation System
-
DecisionDx®-SCC Significantly Improves Prediction Accuracy of Metastatic Events after Mohs Surgery in New Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Tumors of the Head and Nec
-
Premier American Uranium Commences Trading on the OTCQB Marketplace
-
Frontier Reports First-Quarter 2024 Results
-
AXIL Signs Agreement with Kinsey’s for Distribution of Hearing Protection and Enhancement Products
-
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Industry Leaders Tint World® and XPEL Announce Partnership
-
All Three Leading Independent Proxy Advisory Firms Recommend Norfolk Southern Shareholders Vote “FOR” Significant Boardroom Change on the BLUE Proxy Card
-
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
-
The Tel Aviv Stock Exchange (TASE) Schedules First Quarter 2024 Results Release and Conference Call for Wednesday, May 22, 2024
-
Papa Johns Declares Quarterly Dividend
-
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
-
Bowman Closes On $100 Million Revolving Credit Agreement
-
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
-
Galera Adopts Limited Duration Stockholder Rights Agreement
-
2seventy bio to Report First Quarter 2024 Financial Results on May 8, 2024
-
Plug Signs MOU with Allied Green Ammonia for 3GW of Electrolyzer Supply at World-Class Green Ammonia Production Facility
-
Balchem Corporation Reports First Quarter 2024 Financial Results
-
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro
-
Telesat First Quarter 2024 Earnings Conference Call
-
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
-
ECARX Releases Multiple Intelligent Driving Features for Skyland Pro
-
BW Offshore: Closing of the sale of the FPSO Polvo to BW Energy
-
Perella Weinberg Reports First Quarter 2024 Results
-
Brookfield Renewable Reports Record First Quarter Results
-
CBRE Group, Inc. Reports Financial Results for First-Quarter 2024
-
Trimble Announces First Quarter 2024 Results
-
Green Plains Reports First Quarter 2024 Financial Results
-
Cryptnox Launches new Mobile App for Managing Fido2 Security Keys on the Apple Store
-
YieldMax™ ETFs Announces Monthly Distributions on CONY (109.51%), MSTY (103.22%), NFLY (67.74%), SQY (61.75%), PYPY (56.74%) and Others
-
TotalEnergies: Ordinary and Extraordinary Shareholders’ Meeting on May 24, 2024, Conditions of Availability of the Preparatory Documents
-
DHT Holdings, Inc. to announce first quarter 2024 results on Tuesday, May 14, 2024.
-
TransUnion Declares First Quarter 2024 Dividend of $0.105 per Share
-
Fluor Reports First Quarter 2024 Results
-
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024
-
Emerald of Katong: Crafting the Future of Heritage Luxury in Singapore's District 15
-
OfficeCatch Introduces New 3D Filaments to its Extensive Collection